factive


Also found in: Medical, Wikipedia.

factive

(ˈfæktɪv)
adj
(Logic) logic linguistics philosophy (of a linguistic context) giving rise to the presupposition that a sentence occurring in that context is true, as John regrets that Mary did not attend
References in periodicals archive ?
New Antibiotic Warning: The FDA is beefing up warnings about the risk of developing tendonitis and tendon rupture while taking the antibiotics Levaquin, Cipro, Avelox, Floxin, Factive, and Noroxin.
During the first quarter of 2007, the company expects to record approximately $12 million in revenue from ANTARA and approximately $11 million in revenues from FACTIVE (gemifloxacin mesylate) tablets.
In the first quarter of 2007, approximately 99,000 revenue generating prescriptions for FACTIVE were dispensed.
has completed enrollment in its Phase IV post-marketing trial for its fluoroquinolone antibiotic, FACTIVE (gemifloxacin mesylate) tablets.
With more than one million patients treated worldwide, FACTIVE is an important option for physicians treating serious lower respiratory tract infections.
Under the terms of the agreement, Cornerstone will pay Oscient $5 million plus the value of FACTIVE inventory at closing and a royalty on Cornerstone's sales of FACTIVE, less certain adjustments, through the fifth anniversary of the closing date.
This news release contains forward-looking statements made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995, including statements with regard to (i) the Company's intentions to discontinue the sales force promotion of ANTARA and FACTIVE and the corresponding elimination of sales, marketing and corporate positions, (ii) the continued availability of ANTARA and FACTIVE to physicians and patients, (iii) the Company's ongoing review of strategic alternatives, (iv) the Company's projections that it has cash to continue operations into the third quarter of 2009, and (v) the ability of the Company to maintain operations and/or seek bankruptcy protection in the event it is unable to obtain adequate financing or pay its indebtedness as it becomes due.
For the fourth quarter of 2008, the Company reported a net loss from operations of ($50,905,000), which includes a $50,759,000 one-time, non-cash impairment charge on FACTIVE intangible assets, compared to a ($5,854,000) net loss from operations in the fourth quarter of 2007.
As we enter into the fourth quarter, our team remains focused on recalibrating our balance sheet through a convertible debt exchange transaction, securing additional products for our sales force and growing revenues for both ANTARA and FACTIVE.